Amplius Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,253
Closed -$216K 181
2025
Q4
$216K Sell
2,253
-477
-17% -$46.3K 0.02% 168
2025
Q3
$260K Sell
2,730
-234
-8% -$21.5K 0.02% 152
2025
Q2
$258K Buy
+2,964
New +$251K 0.02% 174
2022
Q3
Sell
-5,171
Closed -$464K 170
2022
Q2
$464K Sell
5,171
-1,785
-26% -$181K 0.08% 96
2022
Q1
$771K Buy
6,956
+3,316
+91% +$350K 0.12% 73
2021
Q4
$376K Buy
+3,640
New +$422K 0.05% 132

Other funds holding MDT

Amplius Wealth Advisors's MDT Position: Q1 2026 in Review

Amplius Wealth Advisors sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,253 shares — an estimated $216K sold.

Amplius Wealth Advisors first reported a position in MDT in Q4 2021 and held it in 6 quarters. The position peaked at $771K in Q1 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Amplius Wealth Advisors reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Amplius Wealth Advisors sold 2,253 Medtronic shares in Q1 2026, an estimated $216K.
  • Amplius Wealth Advisors first reported a position in Medtronic in Q4 2021 and held it in 6 quarters.
  • Amplius Wealth Advisors's Medtronic position peaked at $771K in Q1 2022.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Amplius Wealth Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.